News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
51 Results
Section
Business (15)
Drug Development (15)
News (31)
Policy (1)
Tag
Alliances (10)
Cancer (1)
Clinical research (16)
Earnings (2)
Events (1)
Legal (1)
People (3)
Phase 1 (1)
Phase 2 (1)
Phase 3 (14)
Pipeline (4)
Regulatory (1)
Date
Last 365 days (4)
2026 (4)
2023 (1)
2022 (1)
2020 (3)
2019 (2)
2018 (2)
2017 (5)
2016 (4)
2014 (1)
2013 (3)
2011 (10)
2010 (5)
Location
Asia (5)
Europe (8)
United States (1)
Virginia (1)
51 Results for "europharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
George Medicines advances its global commercial strategy for GMRx2 with an exclusive licensing agreement with Orient EuroPharma in Southeast Asia
February 25, 2026
·
6 min read
Business
OncoVent, a Subsidiary of Hepalink, Enters into a License and Distribution Agreement with Orient EuroPharma for the Immunotherapeutic Candidate Oregovomab
OncoVent Co., Ltd., a majority-controlled subsidiary of Shenzhen Hepalink Pharmaceutical Group Co., Ltd., yesterday entered into a license agreement with Orient EuroPharma Co., Ltd..
March 28, 2023
·
5 min read
Press Releases
TaiMed Biologics (4147) Receives TFDA Drug License Collection Notice for Trogarzo, Marking the Final Step Toward Commercial Launch in Taiwan
July 7, 2026
·
4 min read
Press Releases
CEL-SCI to Launch FDA Registration-Enabling Phase 3 Confirmatory Study to Bring Multikine® to Market for Newly Diagnosed Head and Neck Cancer
July 13, 2026
·
6 min read
Business
AEterna Zentaris, Orient Europharma Co., Ltd. Sign License Agreement for Zoptrex
July 1, 2016
·
6 min read
Press Releases
George Medicines signs exclusive licensing agreement with Ahngook Pharmaceutical to commercialize GMRx2 in Korea
March 11, 2026
·
5 min read
Business
Orient Europharma Co., Ltd. And Debiopharm Announce Their Partnership And The Launch Of Pamorelin®LA In Singapore
May 27, 2014
·
3 min read
Business
Summit Enters Into License and Commercialisation Agreement With Eurofarma for Latin American Rights to Ridinilazole, Summit’s Precision Antibiotic in Development for the Treatment of CDI
Summit announces that it has entered into an exclusive license and commercialisation agreement granting EuroPharma rights in Latin America to Summit’s precision antibiotic ridinilazole in development for the treatment of CDI.
December 21, 2017
·
9 min read
BioMidwest
EuroPharma Exclusive Distributor of BCM-95 and BosPure
December 17, 2009
·
2 min read
Drug Development
CEL-SCI Announces Start of Multikine Phase III Study by Orient Europharma Co., Ltd. in Taiwan
June 23, 2011
·
1 min read
1 of 6
Next